|
⚲
|
| Keyboard |
| Ouzren Nawal
✚
|
|
|---|---|
| CIK # | 0001846836 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001846836] | |
| 4 | [0001846836] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Arena Pharmaceuticals Inc | |
| Ouzren Nawal |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Arena Pharmaceuticals Inc ARNA
Common Stock
|
2022-03-11 | Other | 3,665 | ||
|
Arena Pharmaceuticals Inc ARNA
Common Stock
|
2022-03-11 | Other | 890 | ||
|
Arena Pharmaceuticals Inc ARNA
Stock Option (right to buy) · derivative
|
2022-03-11 | Disposed to issuer | 1,666 | ||
|
Arena Pharmaceuticals Inc ARNA
Stock Option (right to buy) · derivative
|
2022-03-11 | Disposed to issuer | 7,202 | ||
|
Arena Pharmaceuticals Inc ARNA
Stock Option (right to buy) · derivative
|
2022-03-11 | Disposed to issuer | 2,500 | ||
|
Arena Pharmaceuticals Inc ARNA
Stock Option (right to buy) · derivative
|
2021-06-11 | Grant | 7,202 | $0.00 | |
|
Arena Pharmaceuticals Inc ARNA
Common Stock
|
2021-06-11 | Grant | 3,067 | $0.00 | |
|
Arena Pharmaceuticals Inc ARNA
Common Stock
|
2021-02-12 | Grant | 595 | $0.00 | |
|
Arena Pharmaceuticals Inc ARNA
Stock Option (right to buy) · derivative
|
2021-02-12 | Grant | 1,666 | $0.00 | |
|
Arena Pharmaceuticals Inc ARNA
Stock Option (right to buy) · derivative
|
2021-02-12 | Grant | 2,500 | $0.00 | |
|
Arena Pharmaceuticals Inc ARNA
Common Stock
|
2021-02-12 | Grant | 893 | $0.00 |